0001567619-22-012194.txt : 20220602
0001567619-22-012194.hdr.sgml : 20220602
20220602182510
ACCESSION NUMBER: 0001567619-22-012194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220531
FILED AS OF DATE: 20220602
DATE AS OF CHANGE: 20220602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burkavage Brian
CENTRAL INDEX KEY: 0001865633
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 22992364
MAIL ADDRESS:
STREET 1: C/O PASSAGE BIO, INC.
STREET 2: ONE COMMERCE SQUARE, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
doc1.xml
FORM 4
X0306
4
2022-05-31
0
0001865494
IO Biotech, Inc.
IOBT
0001865633
Burkavage Brian
C/O IO BIOTECH, INC.
OLE MAALOES VEH 3
COPENHAGEN
G7
2200
DENMARK
0
1
0
0
Chief Accounting Officer
Stock Option (Right to Buy)
4.83
2022-05-31
4
A
0
20000
0
A
2032-05-31
Common Stock
20000
20000
D
One-fourth of these options vest on 5/31/2023, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.
/s/ Brian Burkavage
2022-06-02